"HLA-A24 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*24 allele family.
| Descriptor ID |
D059871
|
| MeSH Number(s) |
D12.776.395.550.489.400.240 D12.776.543.550.439.400.240 D23.050.301.500.100.400.240 D23.050.301.500.450.370.240 D23.050.705.552.100.400.240 D23.050.705.552.450.370.600
|
| Concept/Terms |
HLA-A24 Antigen- HLA-A24 Antigen
- Antigen, HLA-A24
- HLA A24 Antigen
- HLA A24
- HLA-A24
|
Below are MeSH descriptors whose meaning is more general than "HLA-A24 Antigen".
Below are MeSH descriptors whose meaning is more specific than "HLA-A24 Antigen".
This graph shows the total number of publications written about "HLA-A24 Antigen" by people in this website by year, and whether "HLA-A24 Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HLA-A24 Antigen" by people in Profiles.
-
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer. Clin Immunol. 2021 04; 225:108679.
-
SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity. Cancer Immunol Res. 2017 08; 5(8):618-629.
-
Autophagy creates a CTL epitope that mimics tumor-associated antigens. PLoS One. 2012; 7(10):e47126.
-
Interleukin-13 receptor a2: glioma's unlucky receptor? Cytotherapy. 2012 Jul; 14(6):645-6.
-
Merkel cell polyomavirus-specific CD8? and CD4? T-cell responses identified in Merkel cell carcinomas and blood. Clin Cancer Res. 2011 Nov 01; 17(21):6671-80.
-
Identification and characterization of three novel HLA alleles, HLA-A*240214, HLA-A*3215 and HLA-DQB1*060302. Tissue Antigens. 2007 Dec; 70(6):511-4.
-
Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope. Int J Cancer. 2007 Feb 01; 120(3):594-604.